ITGAE and cancer: All and all, this cluster of results suggests that in cancer, CD103loCD11b+ DCs are overall profiled to present antigen, co-stimulate T cells upon antigen presentation and migrate to lymph nodes compared to CD103+ DC1s and DC2s.